American Journal of Tropical Medicine and Hygiene · 2000 · 28 citations · 9 references
Oral Amphotericin BAntifungal AgentMedicineAntifungal AgentsMedicinal FungiAmphotericin BOral MedicineComoro IslandsPharmacotherapyClinical MycologyDermatologyPharmacologyAntimicrobial Resistance
A case of chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was synergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing.
9
Michael A. Pfaller, Ronald N. Jones, Gary V. Doern et al. · Journal of Clinical Microbiology · 1998 · 275 citations · Full text
Distribution and Activity of Amphotericin B in Humans
K. J. Christiansen, E M Bernard, Jonathan Gold et al. · The Journal of Infectious Diseases · 1985 · 229 citations
Combination therapy with antifungal drugs.
Annemarie Polak · PubMed · 1988 · 27 citations